SCHEMBL9219335

SCHEMBL9219335

CC(C)(C)N(C(=O)OCc1ccccc1)[C@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
ITGB3 P05106 1/20 0.46
ITGA2B P08514 1/20 0.46
ABCB1 P08183 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
CTRB1 P17538 2/20 0.44
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ABCC3 O15438 1/20 0.42
NR1I2 O75469 1/20 0.42
ABCB11 O95342 1/20 0.42
NR3C1 P04150 1/20 0.42
RARG P13631 1/20 0.42
CNR1 P21554 1/20 0.42
OPRK1 P41145 1/20 0.42
NR1H2 P55055 1/20 0.42
PPARA Q07869 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4832582 0.95 ALDH1A1 (0.48) ALDH1A1ITGB3ITGA2BABCB1SMN1; SMN2
SCHEMBL4832572 0.95 ALDH1A1 (0.48) ALDH1A1ITGB3ITGA2BABCB1SMN1; SMN2
SCHEMBL31422729 0.89 ALDH1A1 (0.53) ALDH1A1ITGB3ITGA2BABCB1SMN1; SMN2
SCHEMBL5421388 0.89 ALDH1A1 (0.53) ALDH1A1ITGB3ITGA2BABCB1SMN1; SMN2
SCHEMBL15876121 0.89 SLC7A5 (0.43) ALDH1A1ITGB3ITGA2BABCB1SMN1; SMN2
SCHEMBL2957718 0.88 ALDH1A1 (0.51) ALDH1A1ITGB3ITGA2BABCB1SMN1; SMN2
SCHEMBL5146905 0.88 ALDH1A1 (0.51) ALDH1A1ITGB3ITGA2BABCB1SMN1; SMN2
SCHEMBL31087109 0.85 ALDH1A1 (0.49) ALDH1A1ITGB3ITGA2BABCB1SMN1; SMN2
SCHEMBL9697569 0.85 FOLH1 (0.51) ALDH1A1SMN1; SMN2
SCHEMBL7473612 0.83 ALDH1A1 (0.51) ALDH1A1ABCB1SMN1; SMN2MAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113004283-B Tetracyclic compounds as plasma kallikrein inhibitors and uses thereof 成都康弘药业集团股份有限公司 2022-08-12 CN disclosed
CN-113004286-B Tricyclic compounds as plasma kallikrein inhibitors and uses thereof 成都康弘药业集团股份有限公司 2022-08-12 CN disclosed
CN-113004284-B Tetracyclic compounds as plasma kallikrein inhibitors and uses thereof 成都康弘药业集团股份有限公司 2022-08-12 CN disclosed
US-5444061-A Antitumor agents BRITISH TECHNOLOGY GROUP LIMITED (GB) 1995-08-22 US disclosed
WO-1992016512-A1 ANTI-CANCER COMPOUNDS BRITISH TECHNOLOGY GROUP PLC (GB) 1992-10-01 WO disclosed